… for RAI ablation success in intermediate-to-high-risk DTC patients. … risk factors might require
high-dose of 131 I as RAI ablation in accordance with the ATA guideline while RAI ablation …

… Therefore, we assessed the predictive accuracy of the microRNA-based risk score in DTC
… than the ATA risk score. Compared to indolent tumors, a higher risk score was found in …

… Since initial surgery and RAI remnant ablation (RRA) are likely to have a major impact on
risk of recurrence and risk of death in thyroid cancer patients, the failure to incorporate …

… RAI ablation therapy in patients with DTC using propensity score … Thus, RAI ablation remains
controversial in ATA low-risk … RAI ablation in DTC patients according to recurrence risk [8]. …

… Our study based on large-sample data indicated that RAI ablation only benefits
intermediate-risk PTC patients with male gender, age ≥ 45 years and tumor size > 20 mm. …

… iodine (RAI) ablation have shifted away from virtually all cases of papillary thyroid cancer
(PTC) to selected cases of more advanced disease in patients who are at higher risk for … -score …

… When we focused on intermediate-risk patients (n = 480), RAI ablation was performed in 450
patients … We performed Cox regression analysis using the IPTW propensity score due to the …

… for these low risk DTCs. The aim of this study was to validate a new dynamic risk stratification
(… in patients with DTC treated without radioactive iodine (RAI) remnant ablation therapy. …

… In conclusion, the present study identifies the risk factors of recurrence after total
thyroidectomy plus neck dissection and RAI ablation therapy in ATA high-risk PTC patients. …

… in risk 3%, 95% confidence interval, risk decreases 1–4%). In conclusion, radioactive iodine
ablation … the incremental benefit of remnant ablation in low-risk patients treated with bilateral …